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Important advances in understanding the cytoplasmic con-
trol of gene expression occurred in the late 1980s. In those
years, it was shown unambiguously that sequences within the 39
untranslated regions (UTRs) of specific mRNAs direct poly-
adenylation and translational activation in maturing mouse
and frog oocytes. Although before that time polyadenylation
was correlated with translation (see, e.g., reference 66), no
experiments showed a clear cause-and-effect relationship. In
addition, 39 UTRs were generally thought to be rather devoid
of regulatory information—didn’t it make more sense to con-
trol translation at the 59 end? Since then, major inroads have
been made into the biochemistry not only of cytoplasmic
poly(A) addition but also of poly(A) removal. Furthermore, we
can now feel confident that in most cases, poly(A) elongation
confers translational activation while deadenylation promotes
translational silencing. Here, I will focus almost exclusively on
the forces responsible for, and the results of, poly(A) tail
changes during early development. However, a new study in-
dicating that regulated polyadenylation may be important for
adult brain functions is also discussed. For reviews of the
cytoplasmic polyadenylation field prior to 1996, see references
59 and 64. For a discussion of 39 UTRs in general, a number of
sources are available (31, 72, 105). Similarly, there are several
recent reviews on the continually evolving field of nuclear
polyadenylation (11, 99). Finally, for further discussions of
development of translational control and the biochemistry of
protein synthesis, the reader is referred to references 34 and
52.
POLY(A) TAIL CHANGES OCCUR IN EARLY
DEVELOPMENT
The oocytes of probably most animals contain an amount of
mRNA that far exceeds the immediate protein synthesis re-
quirements of the cell. Much of this mRNA, which is dormant
or masked, will be inherited by the egg following fertilization.
At that time, as well as in later embryonic stages, several
mRNAs will be recruited onto polysomes in a sequence-spe-
cific and often location-specific manner. In a number of ver-
tebrates, such as Xenopus and the mouse, some dormant
mRNAs in oocytes will become translationally active prior to
fertilization, during meiotic maturation. Generally, the dor-
mant mRNAs in oocytes have relatively short poly(A) tails,
usually fewer than about 20 nucleotides. During oocyte matu-
ration, the tails on specific mRNAs grow to about 80 to 150
nucleotides, and translation ensues (major exceptions include
histone mRNAs [55]). However, not all mRNAs that undergo
polyadenylation during maturation do so at the same time, for
there appear to be early and late adenylating mRNAs. Also
during maturation, some translating mRNAs that have the
usual long poly(A) tail (;100 to 200 nucleotides) undergo a
deadenylation reaction, which results in their translational re-
pression.
Embryos from invertebrates also display dynamic changes in
polyadenylation. In Drosophila, the regulated poly(A) tail
changes of several mRNAs are essential for correct embryonic
patterning. Superimposed on this regulation, of course, is the
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exquisite control of mRNA localization, which perhaps com-
plicates the analysis of essential sequences and factors. In Cae-
norhabditis elegans, the regulation of mRNA polyadenylation
may be important for sex determination. Finally, while the
biological importance has not yet been elucidated, poly(A)
length changes also occur during the very early development of
several marine invertebrates, such as the surf clam and the sea
urchin.
Polyadenylation in Xenopus Development
cis elements. Due to their ease of microinjection and be-
cause large quantities may be easily obtained for biochemical
fractionation, Xenopus oocytes have proven to be a useful
source material for studying the biochemistry of cytoplasmic
polyadenylation. Although earlier studies had shown that ma-
turing oocytes contain mRNAs that undergo polyadenylation
and commensurate translation (see, e.g., reference 19), it was
not until 1989 that the cis elements necessary for these pro-
cesses were described (20, 53). Two sequences in the 39 UTRs
of responding mRNAs are essential, the near-ubiquitous AAU
AAA, which is also crucial for nuclear pre-mRNA cleavage
and polyadenylation, and a U-rich sequence that often resides
about 20 nucleotides 59 of the hexanucleotide. This is the
cytoplasmic polyadenylation element (CPE), which has the
consensus structure of UUUUUAU. The CPE can support
polyadenylation when it overlaps with the hexanucleotide,
when it is immediately adjacent to it, or when it is up to 100
nucleotides distant (17, 54; see references 64, 78, and 80 for
reviews). However, because the timing of polyadenylation of
different mRNAs varies during maturation, there may be ad-
ditional regulatory information in the CPE itself. For example,
the sequence UUUUUAU may promote polyadenylation ear-
lier during maturation than, say, UUUUAAU, or perhaps the
distance of the CPE from the hexanucleotide influences the
time when given mRNAs undergo this 39 end modification (4,
17). Alternatively, there may be additional 39 UTR sequences
that influence polyadenylation (see, e.g., references 27 and 76).
Before discussing cytoplasmic polyadenylation in detail, it is
important to understand the salient features of oocyte matu-
ration in Xenopus (Fig. 1) (68, 88). Following progesterone
binding to a putative cell surface receptor, there is an essential
but transient decrease in the level of cyclic AMP, which is
thought to activate specific protein kinases (1). These events
then lead to c-mos mRNA polyadenylation and translation.
This is a critical step, because oocytes contain no Mos protein,
and it must be made entirely de novo from mRNA that un-
dergoes cytoplasmic polyadenylation (42, 68, 73, 74). Addi-
tional evidence indicates that other, as yet undefined mRNAs
must also be polyadenylated and translationally activated at
this time (6, 47). Following the synthesis of Mos, which is a
mitogen-activated protein (MAP) kinase kinase kinase, MAP
kinase kinase and MAP kinase are activated by, of course,
phosphorylation. This leads to eventual maturation-promoting
factor (MPF) activation. MPF, which is composed of cyclin B1
and cdc2 (cyclin-dependent kinase type 1 [CDK1]) kinase, is
most directly responsible for the many manifestations of oo-
cyte maturation, such as germinal vesicle breakdown (GVBD)
and chromatin condensation. Importantly, cdc2 kinase is also
involved in a feedback loop of kinase activation, and so it is
sometimes difficult to know with absolute certainty which ki-
nase phosphorylates a given substrate (33).
A time course experiment during maturation reveals that
c-mos mRNA is polyadenylated much earlier than other
mRNAs such as those encoding histone B4 and cyclins A1 and
B1 (4, 17, 72). To determine whether late-adenylating mRNAs
require the early-adenylating mRNA product(s) (e.g., Mos),
c-mos mRNA was ablated by an antisense oligonucleotide.
While this prevented histone B4 and cyclin A1 and B1 mRNAs
from undergoing polyadenylation, it did not inhibit the poly-
adenylation of injected c-mos RNA (4, 17). Thus, mRNAs such
as cyclins A1 and B1 must contain a Mos response element
(MRE), whose polyadenylation function is directly or indi-
rectly influenced by Mos. A mutational analysis of the cyclin B1
39 UTR revealed that one CPE that overlaps with the poly-
adenylation hexanucleotide corresponded to the MRE (17).
Interestingly, the CPE and hexanucleotide of cyclin A1 mRNA
have this same configuration, which corresponds to the MRE
of this transcript. In a similar vein, Ballantyne et al. (4) have
shown that the polyadenylation of certain sets of mRNAs but
not others is sensitive to active cdc2 kinase. Therefore, while it
appears that there are two pathways for polyadenylation dur-
ing maturation, both probably require activation by phosphor-
ylation. In addition, another lesson that should clearly be
drawn from these studies is that we can no longer discuss
cytoplasmic polyadenylation in generic terms—rather, we must
refer to this process with specific mRNAs in mind. Of course,
this has important implications when determining the activity
of polyadenylation-inducing factors; the RNA substrate that is
used would clearly be crucial.
Oocytes cultured in both progesterone and cycloheximide
fail to undergo meiotic maturation. However, oocytes cultured
in cycloheximide that are injected with Mos protein do un-
dergo maturation, indicating that Mos synthesis is all that is
required for maturation (68, 69). On the other hand, a subse-
quent study that examined c-mos mRNA polyadenylation and
translation suggests that the situation may be more complex. In
this case, Sheets et al. (74) injected a “prosthetic” RNA into
oocytes that would anneal with the 39 UTR of c-mos mRNA.
FIG. 1. Critical events during Xenopus oocyte maturation. Progesterone binds a
putative cell surface receptor, which leads to a transient decrease in cyclic AMP
(cAMP) levels and the activation of Eg2 kinase. Subsequently, dormant c-mos
mRNA undergoes polyadenylation-induced translational activation. Newly syn-
thesized Mos, a serine/threonine kinase, activates MAP kinase kinase (MAP
kinase cascade), which culminates in the activation of MPF (a heterodimer com-
posed of cyclin B and cdc2). Active MPF, which phosphorylates a number of
substrates, is most directly responsible for the manifestations of oocyte maturation.
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Because the prosthetic RNA also contained a poly(A) tail, it
induced the translation of c-mos mRNA. However, such in-
jected oocytes would mature only if they were also incubated in
progesterone. Taken at face value, these data suggest that in
addition to Mos, the synthesis of another protein(s) must occur
for oocyte maturation to proceed. Recent data from Barkoff et
al. (6) also indicate that this is the case, but they go further and
suggest that, like Mos, the synthesis of this other essential but
undefined protein is the result of mRNA cytoplasmic polyade-
nylation-induced translation. This general conclusion was also
reached by Kuge et al. (47).
As noted earlier, some Xenopus mRNAs undergo poly(A)
elongation only during embryogenesis. For many mRNAs, poly-
adenylation at this time requires the hexanucleotide AAU
AAA and a CPE. Here, however, this CPE is of the “embry-
onic” type, which is oligo(U)12–27 (75–77). While the mRNAs
that are polyadenylated during maturation often encode cell
cycle-regulatory proteins (Mos, cyclins, cdk2, etc.), those that
are polyadenylated in the embryo may be important for germ
layer formation or patterning. For example, activin receptor
mRNA, which is involved in mesoderm induction, undergoes
polyadenylation and translation in the embryo, and interfer-
ence with this process results in embryos with a number of
morphological defects (77).
To date, the embryonic-type CPE is the only clearly defined
sequence that promotes polyadenylation in embryos. However,
Verrotti et al. (97) have shown that Drosophila bicoid mRNA,
which contains no element that obviously resembles a CPE,
also undergoes polyadenylation in injected Xenopus embryos.
These data indicate that there is at least one more sequence
that promotes embryonic polyadenylation.
trans factors. In its simplest form, polyadenylation during
maturation must involve at least three factors: one that binds
the CPE, one that binds the hexanucleotide, and, of course,
poly(A) polymerase (PAP). The CPE is bound by CPEB, an
RNA recognition motif (RRM)- and zinc finger-containing
protein that has putative homologues in other vertebrates and
in invertebrates (5, 25, 36, 100). While initial studies suggested
that the phosphorylation of CPEB was important for the acti-
vation of polyadenylation (62), recent evidence indicates that it
is more likely to be involved in the eventual destruction of the
protein (17). In addition, phosphorylation does not appear to
influence RNA binding (35).
To examine the importance of CPEB in vivo, antibody to this
protein was injected into oocytes. Not only did this treatment
inhibit the polyadenylation of c-mos mRNA, but also it abro-
gated the synthesis of Mos. Thus, it is not surprising that CPEB
antibody injection also prevented oocyte maturation (78).
These data therefore confirm the original in vitro experiments
demonstrating that the immunodepletion of CPEB from egg
extracts rendered them incompetent for polyadenylation (36).
It has been suggested that one possible function of CPEB is
to recruit or stabilize factors that interact with the hexanucle-
otide, which in turn might serve as an anchor for poly(A)
polymerase (PAP) (7, 36). Initial biochemical fractionation
experiments by Fox et al. (22) indicated that the hexanucle-
otide could be bound by cleavage and polyadenylation speci-
ficity factor (CPSF), which is well known for its role in nuclear
pre-mRNA polyadenylation (99). Subsequently, Bilger et al.
(7) noted that heterologous CPSF and PAP stimulated poly-
adenylation in a CPE-dependent manner. However, U-rich
sequences upstream and downstream of the AAUAAA are
known to facilitate nuclear CPSF activity (29), and so it is
unclear if the results of Bilger et al. (7) are a recapitulation of
the nuclear activity. At present, there are no data demonstrat-
ing, say, an inhibition of egg extract polyadenylation following
CPSF immunodepletion. In the absence of results of this kind,
it is difficult state with certainty that CPSF is involved in cyto-
plasmic polyadenylation.
The third factor that is essential for polyadenylation is PAP.
Xenopus oocytes, like many somatic cells, have multiple forms
of this enzyme (3, 24, 110, 111), one of which lacks a nuclear
localization signal and hence would be expected to be entirely
cytoplasmic (24). While this protein has PAP activity when
expressed in bacteria, it has not been detected in oocytes.
Therefore, whether cytoplasmic polyadenylation utilizes a spe-
cial (i.e., nonnuclear) form of the enzyme is unclear. However,
it should be borne in mind that the “nuclear” form of the
enzyme is also cytoplasmic in oocytes (3), and so it is certainly
possible that this enzyme catalyzes polyadenylation in both
compartments (but see below).
During oocyte maturation, cdc2 kinase phosphorylates PAP
at a number of sites (3, 13). Interestingly, as the enzyme be-
comes hyperphosphorylated, it becomes progressively less ac-
tive (12, 13), such that by late maturation it has virtually no
activity at all (13). This would seem paradoxical because there
is robust cytoplasmic polyadenylation activity at this time. Per-
haps this indicates that there is at least one form of PAP that
is not inactivated by phosphorylation.
Recent evidence suggests that the CPE and CPEB have a
second function, that of mRNA masking (18). In oocytes, cy-
clin B1 mRNA has a short poly(A) tail and is translationally
dormant. During maturation, the poly(A) tail is elongated and
translation ensues. While this scenario seems straightforward
vis-a`-vis mRNA activation, it does not delineate the mecha-
nisms responsible for the initial translational repression of the
mRNA. To address this, deMoor and Richter (18) began with
the assumption that cyclin B1 mRNA might be bound by a
repressor protein (perhaps analogous to FRGY2 [9]), which
could be competed off by multiple exogenous copies of the
binding site. Therefore, they injected various portions of cyclin
B1 RNA into oocytes and determined whether endogenous
cyclin B1 protein was synthesized. Interestingly, injection of
the B1 RNA 39 UTR induced cyclin B1 synthesis. A mutational
analysis subsequently revealed that it was the CPE itself that
was responsible for the translational unmasking and that the
strength of the unmasking was correlated with the number of
CPEs injected. Furthermore, while a reporter mRNA could be
masked if it was appended with a CPE-containing 39 UTR, it
had to undergo cytoplasmic polyadenylation before it could be
translated during maturation. Therefore, the CPE acts both
negatively (as a repressor of translation) and positively (as an
activator of polyadenylation-induced translation).
How could the CPE perform both tasks? Clearly, that de-
pends on the nature of the interacting proteins. deMoor and
Richter (18) identified CPEB as the only CPE binding protein.
Thus, could CPEB both repress and enhance translation? A
model to explain how this could be so is presented in Fig. 2, a
key feature of which is a putative CPEB binding protein. Here,
they suggest that in immature oocytes, CPEB binds not only
the CPE but also a factor “X” protein. Factor X, in turn, might
interact with the cap or with a translation initiation factor such
as eIF-4E to prevent translation. When the cyclin B1 39 UTR
is injected into oocytes, CPEB and factor X might compete off
endogenous cyclin B1 mRNA, thereby releasing it for transla-
tion. During the normal course of oocyte maturation, however,
it may be that polyadenylation, which is necessary for unmask-
ing, disrupts the CPEB-factor X interaction to allow transla-
tion to begin. While further experimentation could certainly
cause revisions to this model, it is noteworthy that Stutz et al.
(85, 86), have obtained somewhat similar data with maturing
mouse oocytes (but with a notable exception—in these mam-
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malian cells, mRNA unmasking does not require polyadenyla-
tion [see below]).
A single factor has been described in Xenopus that is thought
to be involved in embryonic cytoplasmic polyadenylation. A
36-kDa protein, which was subsequently identified as ElrA
(108), was shown to UV cross-link to the oligo(U)12–27 embry-
onic CPE (75, 77). ElrA is a member of the ELAV family of
RNA binding proteins (30, 65). While ElrA binds quite spe-
cifically to the oligo(U)12–27 CPE, both in vitro and in vivo, its
role in polyadenylation has not been conclusively demonstrat-
ed. Interestingly, however, a dominant negative form of the
protein inhibits normal gastrulation in injected embryos, quite
possibly because the polyadenylation-induced expression of an
essential mRNA(s) is disrupted.
Deadenylation in Xenopus Development
cis element. Ribosomal-protein mRNAs exemplify those
transcripts that are deadenylated and translationally silenced
during oocyte maturation (93, 94). These mRNAs have no
specific sequence that directs deadenylation; rather, they un-
dergo this reaction by default because they contain no CPE to
promote poly(A) addition at this time (21, 94). In contrast to
the situation during oocyte maturation, deadenylation in the
embryo requires mRNA-specific cis elements. Cdk2 mRNA,
for example, undergoes CPE-directed polyadenylation at matu-
ration but is deadenylated soon after fertilization. Two se-
quences within the 39 UTR of this mRNA direct embryo-
specific deadenylation; one, composed of 58 nucleotides, is
immediately upstream of the CPE, while the other, composed of
14 nucleotides, is 39 of the hexanucleotide. While each element
promotes partial deadenylation individually, together they
appear to act synergistically to promote complete de-
adenylation (79). While seemingly discrete in nature, these
cdk2 cis-deadenylation elements are not obviously present in
other mRNAs that undergo this reaction at this time.
Other RNAs contain a different embryonic deadenylation
element, sometimes referred to as the EDEN sequence (2, 8,
48, 49). This is a 17-nucleotide, somewhat internally repetitious
sequence in the 39 UTRs of Eg2, Eg5, and c-mos mRNAs (8,
60). Like the 39 cdk2 embryonic deadenylation element, the
EDEN sequence can confer specific deadenylation to a report-
er RNA (60).
Finally, it has recently been shown that an AU-rich element
normally thought to promote mRNA degradation in a variety
of systems (10), AUUUA, mediates deadenylation in Xenopus
embryos (98). Although this might appear surprising on the
surface, it has been shown that in mammalian tissue culture
cells, deadenylation precedes mRNA decay (10). For Xenopus
embryos, it appears that the first-step deadenylation reaction is
temporally uncoupled from mRNA destruction, which nor-
mally occurs at the 4,000-cell mid-blastula stage, several hours
after deadenylation.
trans factors. During oocyte maturation, dissolution of the
nuclear envelope, i.e., GVBD, precedes and is essential for
default deadenylation. This suggests that at least one factor
involved in this process must be sequestered in the nucleus
prior to GVBD (92). While the nature of this factor has not yet
been firmly established, significant progress has been made in
addressing the underlying mechanisms of deadenylation with
the isolation and cloning of two proteins, the first of which is a
deadenylating nuclease [DNA, subsequently referred to as a
poly(A)-specific RNase (PARN) (45)]. This protein, a member
of the RNase D family initially isolated from mammalian so-
matic tissue (44), is mostly cytoplasmic in HeLa cells, but its
localization in oocytes is less clear. In these cells, two proteins,
of 62 and 74 kDa, are detected on a Western blot. The 62-kDa
species is cytoplasmic, while the 74-kDa species is nuclear.
While the relationship, if any, between these two proteins is
unknown, the 74-kDa protein may correspond to the func-
tional deadenylase. This conclusion is based on the observa-
tions that (i) proper default deadenylation requires a nuclear
component that must be released after GVBD and (ii) cyto-
plasmic extracts have little deadenylation activity. Irrespective
of which of these two proteins is the true PARN, perhaps the
most important result is that antibody raised against the mam-
malian protein, when injected into oocytes, prevents default
deadenylation (45). With the PARN cDNA clone now in hand,
the molecular regulation of deadenylation, in maturing oocytes
as well as in embryos, may soon be elucidated.
A second, recently cloned factor that is important for de-
adenylation specifies which mRNAs lose their poly(A) tails
after fertilization. Following the earlier work of Bouvet et al.
(8), who identified a 53- and 55-kDa protein doublet that bound
the EDEN sequence, Paillard et al. (60) isolated and cloned a
cDNA for this factor, referred to as EDEN-BP. The necessity
of EDEN-BP for the deadenylation of specific RNAs was dem-
onstrated by using egg extracts. While these extracts support
EDEN-dependent Eg2 deadenylation, they fail to do so fol-
lowing EDEN-BP immunodepletion. Interestingly, EDEN-BP
shows high homology to two other proteins, which suggests
that it may be a multifunctional protein. The first protein is
human Nab50/CUG-BP (60, 92), which is 88% identical to the
Xenopus protein. Nab50/CUG-BP, whose only known function
FIG. 2. Model for CPE-mediated translational repression and activation. In
immature oocytes, CPEB binds both the CPE and a hypothetical factor, factor X.
Factor X, in turn, prevents translation either by interacting with the cap or by
preventing eukaryotic initiation factors (i.e., eIF-4E) from recognizing the cap. A
possible hexanucleotide binding factor (HNBF), which could be CPSF, is also
indicated. Following oocyte maturation, CPEB induces cytoplasmic polyadenyla-
tion, which disrupts CPEB-factor X interaction and allows initiation factor bind-
ing to the cap and translation initiation.
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is that it binds CUG repeats, may be involved in myotonic
dystrophy, because one characteristic of this disease is a CUG
repeat expansion in the 39 UTR of myotonin protein kinase
mRNA. The second protein with homology to EDEN-BP is
Drosophila Bruno (101). Bruno protein is a translational re-
pressor of oskar mRNA, whose localized expression is critical
for posterior body patterning (43). While it is possible that
Nab50/CUG-BP and Bruno regulate mRNA expression by de-
adenylation, there is currently no evidence indicating that this
is the case. Thus, it may be that this family of RNA binding
proteins controls translation in multiple ways. A summary of
the essential features of poly(A) additional and removal during
Xenopus development is presented in Fig. 3.
Polyadenylation in Early Mouse Development
cis elements. Many features of oocyte maturation in Xenopus
also take place in the mouse, including cytoplasmic polyade-
nylation (26). At least for tissue-type plasminogen activator
(tPA) (37), c-mos (27), spindlin (57), and cyclin B1 (87) mRNAs,
the same cis elements used in Xenopus are used in the mouse.
That is, a structure closely resembling the UUUUUAU-type
CPE, also called the adenylation control element (ACE), and
the AAUAAA hexanucleotide are required. Other RNAs that
are polyadenylated during maturation have these sequences,
although mutagenesis experiments have not been performed to
establish that they are necessary (38, 58, 63, 96, 103).
In contrast to Xenopus, most maternal mRNAs in the mouse
are destroyed by the two-cell stage, when the zygotic genome
becomes active. Thus, one might surmise that maternally in-
herited mRNAs would play a lesser role in this species. While
this might be the case, recent studies indicate that cytoplasmic
polyadenylation and presumably translational activation occur
soon after fertilization in the mouse, suggesting at least some
important roles for maternal mRNAs. Putative CPEs (either
the maturation type or the embryonic type) are present in two
transcripts that are polyadenylated after fertilization, catenin
mRNA (58) and another mRNA of unknown function (90).
Interestingly, Oh et al. (57) have recently shown that not only
does spindlin mRNA undergo polyadenylation during oocyte
maturation and after fertilization but also its 39 UTR contains
a maturation-type and an embryonic-type CPE.
trans factors. Because the UUUUUAU-type CPE controls
polyadenylation during mouse oocyte maturation, it is perhaps
not surprising that this sequence is bound by CPEB (25). The
frog and murine proteins are highly homologous, especially
in the carboxy-terminal, RNA binding portion of the protein.
Like the frog protein, mouse CPEB is phosphorylated during
maturation (89), although the function of this modification is
unknown.
Stutz et al. (86) have taken a novel approach to the study of
factors involved in cytoplasmic polyadenylation. These inves-
tigators injected oocytes with antisense oligodeoxynucleotides
complementary to various regions of tPA mRNA; they then
examined the expression of this mRNA by the sensitive zymog-
raphy assay. The rationale behind such an experiment is that
sequences that are, say, bound by regulatory proteins would be
inaccessible to oligonucleotide binding, and hence, RNase H-
mediated RNA digestion would not occur. The result would
then be robust tPA activity, which could be quantified by zy-
mography. Perhaps not surprisingly, Stutz et al. (86) showed
that the CPE/ACE and the AAAAA were protected from
RNase H-mediated cleavage. However, a somewhat unexpect-
ed finding was that early during maturation, a portion of the
CPE/ACE and the hexanucleotide became accessible to oligo-
nucleotide annealing and resulting mRNA cleavage. From this,
Stutz et al. (86) concluded that the mRNA becomes unmasked
prior to polyadenylation.
In a follow-up study, Stutz et al. (85) showed that endoge-
nous tPA mRNA is translationally activated when oocytes are
FIG. 3. Essential features of poly(A) addition and removal during Xenopus development. In oocytes, CPEB binds the CPE and shifts an equilibrium between
poly(A) tail growth or removal in the direction of growth. For mRNAs that do not contain a CPE, the equilibrium is shifted toward poly(A) tail removal, which is often
referred to as default deadenylation. The enzyme responsible for deadenylation is PARN. HNBF refers to hexanucleotide binding factor. During embryogenesis,
poly(A) tail elongation is directed by an embryonic-type CPE (eCPE), which is oligo(U)12–27. The eCPE is bond by the protein elrA, a member of the ELAV family
of RNA binding proteins. In contrast to oocyte maturation, deadenylation in embryos is directed by the EDEN cis element. The EDEN sequence is bound by the protein
EDEN-BP, which may interact, directly or indirectly, with PARN.
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injected with fragments of RNA that contain the CPE/ACE. In
this sense, then, this is similar to what deMoor and Richter
(18) observed with cyclin B1 mRNA in injected Xenopus oo-
cytes (see above). However, one major difference in these
studies is that while polyadenylation is required to unmask
cyclin B1 mRNA in Xenopus oocytes, it is not required to
unmask tPA mRNA in mouse oocytes. Rather, Stutz et al. (85)
suggest that an 80-kDa protein, which binds the CPE/ACE,
must be removed from that sequence to allow translation to
occur. While this would suggest that polyadenylation plays
no role in translational activation, these investigators found
that the unmasking event requires a short (;30-nucleotide)
poly(A) tail. Thus, they surmised that the maturation-specific
polyadenylation of tPA mRNA is necessary to prevent default
deadenylation, which, if it occurred, would maintain transla-
tional arrest. Indeed, Huarte et al. (37) found that the deade-
nylation of tPA mRNA that occurs during oocyte growth is
important for the initial translational repression. As for the 80-
kDa protein, its identity is unknown, but on sodium dodecyl
sulfate-polyacrylamide gels, its relative mobility is similar to
that of mouse CPEB (25).
Polyadenylation in Drosophila Development
cis elements. Axis formation in the Drosophila embryo re-
quires the precise temporal and spatial expression of a number
of mRNAs (14, 16, 83). While the translation of maternal
mRNA in this species is probably controlled at multiple levels,
one important mechanism is the modulation of poly(A) tail
length. For example, bicoid, Toll, and torso mRNAs, all of which
play important roles in body patterning, undergo poly(A) elon-
gation and translational activation (70). The mRNA selectivity
for this reaction is demonstrated by the fact that nanos mRNA,
which is translationally activated at nearly the same time as the
three aforementioned mRNAs, displays no obvious poly(A)
tail length change (23, 70).
Schisa and Strickland (71) have investigated the cis elements
responsible for cytoplasmic polyadenylation of Toll mRNA.
They found that in contrast to vertebrates, there are no small,
discrete, polyadenylation-inducing signals. Rather, these inves-
tigators noted that a 192-nucleotide element, when deleted
from the Toll mRNA 39 UTR, abrogates polyadenylation but
by itself cannot induce polyadenylation. Schisa and Strickland
(71) further suggested that there may be several nonhomolo-
gous regions of Toll RNA that can direct polyadenylation.
trans factors. Given that very little is known about the cis
elements that direct polyadenylation in Drosophila, one might
surmise that nothing would be known about the proteins that
directthisprocess.However,usingageneticapproach,theStrick-
land laboratory has identified two genes that may be involved.
Lieberfarb et al. (50) examined a number of female-sterile
mutations for the possible down-regulation of bicoid gene ex-
pression. Two mutations, cortex and grauzone, were indeed found
to be correlated with reduced bicoid levels. Most importantly,
neither bicoid nor Toll mRNA undergoes cytoplasmic polyade-
nylation in either of these mutant embryos. Moreover, nanos
mRNA, whose expression does not involve changes in poly(A)
tail length, is translated in cortex embryos. Thus, the proteins
encoded by cortex and grauzone may be a part of the polyade-
nylation complex. Two other proteins that could be important
in Drosophila polyadenylation have been identified by UV
cross-linking to the Toll mRNA 192-nucleotide polyadenyla-
tion element (71). Other than RNA binding, however, only the
sizes of these proteins (101 and 89 kDa) are known.
Deadenylation in Drosophila Development
trans factors. In Drosophila embryos, the localized transla-
tional repression of specific mRNAs is essential for correct axis
formation. At least one mRNA, hunchback, appears to be re-
pressed via cytoplasmic deadenylation. While nothing is known
of the cis elements that control the deadenylation of this mRNA,
some gene products have been identified that may be involved
in this process. It has been known for several years that nanos
mRNA, which resides exclusively in the posterior pole of the
Drosophila embryo, is essential for structures that later arise
from that location. Nanos protein appears to function as a
translational repressor. That is, it is important that the expres-
sion of hunchback mRNA, which is distributed uniformly in
the embryo, be limited to the anterior pole. Thus, it is Nanos
protein that suppresses the translation of hunchback mRNA in
the posterior pole (39, 84). The region of hunchback mRNA
that is important for the translational repression imposed by
Nanos is the 39 UTR, and discrete nanos-responsive elements
(NREs) within this region have been defined (104). What would
appear to be a somewhat straightforward situation of transla-
tional repression is made more complicated by the fact that
Nanos does not bind the NRE (or at least not with a high
degree of specificity). Instead, the pumillio gene product binds
hunchback NRE (56). However, both Nanos and Pumilio
appear to repress hunchback mRNA translation by inducing
mRNA deadenylation (107). How these factors promote de-
adenylation is unknown, but this process is likely to be an es-
sential step in the generation of abdominal structures.
Deadenylation in Caenorhabditis elegans Development
cis elements and trans factors. In C. elegans, the regulated
translation of a few mRNAs is necessary for sex determination
(31, 105). The sex of these hermaphroditic animals is con-
trolled by the X-to-autosome ratio; XX animals are hermaph-
rodites (basically females that make oocytes and sperm), where-
as XO animals are males. One gene that determines the sex of
the animal is tra-2; when it is deleted, XX animals become
males. The tra-2 gene is regulated at the translational level by
two cis elements in its 39 UTR, referred to as DREs (direct-
repeat elements) or, more recently, as TREs (tra-2 and GLI
elements) (40). The TGE, AAUUUAUU, is required for the
inhibition of tra-2 mRNA expression, which is correlated with
the maintenance of a short poly(A) tail (40).
Immediately upstream of tra-2 is the laf-1 gene, which is a
negative regulator of tra-2 expression (31). One possible func-
tion of the laf-1 protein is that of a deadenylation-inducing
translational repressor of tra-2 mRNA. The inhibition of tra-2
mRNA translation would prevent female development (40). A
factor, tentatively identified as DRF (direct-repeat factor),
which could be the laf-1 gene product, binds the TREs (32, 40).
In transgenic animals, TRE-dependent translational repres-
sion and the maintenance of a short poly(A) tail requires laf-1.
In vitro, the TGEs serve as binding sites for DRF. Thus, while
laf-1 has not yet been cloned and DRF has not yet been iso-
lated, circumstantial evidence suggests that they could be the
same factor.
POLYADENYLATION IN THE CENTRAL
NERVOUS SYSTEM
Although cytoplasmic polyadenylation is a hallmark of early
metazoan development, there is virtually no evidence that it
occurs in adult tissues. From a teleological point of view, this
would seem very inefficient. That is, a significant genetic load is
used to regulate translation by cytoplasmic polyadenylation, so
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why not use the process in adult tissues just as it is used in early
development? Perhaps it is used in adult tissues, but we just
don’t know where to look, or even how to look. What adult
tissues contain dormant mRNAs that must be activated in an
instant? How can we examine polyadenylation in somatic tis-
sues where mRNA injection is extremely difficult?
Clearly, knowing where to look is paramount. In the last few
years, mounting evidence has suggested that the brain might
FIG. 4. Poly(A) tail elongation in the central nervous system. (A) The method used to detect poly(A) tail length is the RT-PCR-based PAT [poly(A) test]. Here,
oligo(dT) fused to a GC-rich anchor will anneal to multiple regions along the length of a poly(A) tail. When it is reverse transcribed, the resulting cDNAs will be
heterogeneous in size. Following PCR with an mRNA-specific primer and the oligo(dT) anchor, the size heterogeneity will be maintained. Thus, mRNAs with long
poly(A) tails will yield cDNAs of diverse sizes, the largest of which will approximate the longest poly(A) tail. On the other hand, mRNAs with short poly(A) tails will
yield smaller cDNAs with discrete sizes. In addition, PCR with two mRNA-specific primers will result in products with discrete sizes (internal control). RT, reverse
transcription. (B) Visual cortices were removed from rats born and raised in the dark (dark rearing) and then either not exposed to light or exposed to light for 30 to
360 min. The visual cortices were also removed from rats maintained on a standard 12-h light-dark cycle (std.). Following RNA extraction, PATs were performed for
a-CaMKII mRNA, which contains a CPE, and neurofilament (NF) mRNA, which does not contain a CPE. The PATs used the same reverse transcription reaction.
The products were resolved on an agarose gel and visualized by ethidium bromide staining. Note that the poly(A) tail of a-CaMKII mRNA was elongated in response
to light, while the poly(A) tail of NF mRNA was unaffected. (C) The a-CaMKII PCR products from panel B were Southern blotted and probed with radiolabeled
a-CaMKII 39 UTR. This blot confirms that the ethidium bromide staining material in panel B corresponds to a-CaMKII sequences and also shows light-dependent
polyadenylation of this mRNA. (D) An aliquot of visual cortex RNA annealed to excess oligo(dT) was incubated with RNase H, which removes the poly(A) tail. This
was followed by a PAT for a-CaMKII mRNA, or reverse transcription-PCR with internal, mRNA-specific primers. This control confirms that the heterogeneously sized
a-CaMKII sequences in panel B resulted from oligo(dT) priming of the poly(A) tail. (E) Reverse transcription-PCR with two a-CaMKII 39 UTR-specific primers was
performed on the same visual cortex RNA used in panel B. This control confirms that the 39 UTR of a-CaMKII mRNA was intact, since the PCR product is discrete
and has the predicted size. Reprinted from reference 109 with permission of the publisher.
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contain dormant mRNAs. In particular, specific mRNAs are
present in dendrites (15, 81), and synaptic spines (regions at
the bases of synapses) have ribosomes and translation initia-
tion factors (82, 91). Most importantly, recent studies indicate
that translational control in dendrites may be important for
long-term changes in synaptic efficacy (41, 51). Even if this
brain activity is regulated at the translational level, how could
one assess whether cytoplasmic polyadenylation is involved?
One approach, taken by Wu et al. (109), was to determine if a
factor that regulates cytoplasmic polyadenylation, CPEB, is
present in the brain. Although CPEB expression is quite re-
stricted in the mouse (25), brain tissue contains readily detect-
able amounts. Furthermore, CPEB is present in the dendritic
layers of the hippocampus, at synapses in cultured hippocam-
pal neurons, and in postsynaptic densities (i.e., large networks
of structural and regulatory proteins immediately beneath the
postsynaptic membrane) of adult brain (109). Thus, the local-
ization of CPEB strongly suggests that it could be involved in
synaptic efficacy.
Of course, the function of CPEB in the brain depends upon
the mRNA(s) to which it is bound. One mRNA, which is pres-
ent in dendrites and known to be essential for the long-lasting
phase of long-term potentiation (L-LTP) encodes Ca21-calmo-
dulin-dependent protein kinase II (a-CaMKII). The 39 UTR of
a-CaMKII mRNA contains UUUUUAU-type CPEs, which
bind CPEB in vitro and which drive polyadenylation-induced
translation in injected Xenopus oocytes. While suggestive, these
data do demonstrate that this process also occurs in the brain.
To examine this, Wu et al. (109) investigated the visual cortex,
which also contains CPEB. In dark-reared rats, there is a
massive activity-driven reorganization in the visual cortex fol-
lowing exposure to light. In this region of the brain, light ex-
posure induces polyadenylation and translation of a-CaMKII
mRNA but does not affect the poly(A) tail length of neuro-
filament mRNA, which does not contain a CPE (Fig. 4). Thus,
cytoplasmic polyadenylation may be essential for L-LTP, which
probably forms the basis for learning and memory.
POLYADENYLATION AND THE MECHANISMS OF
TRANSLATIONAL ACTIVATION
In yeast, the poly(A) tail stimulates translation through sev-
eral protein intermediates, one of which is poly(A) binding
protein. This factor, in turn, interacts with the translation ini-
tiation factor eIF-4G. eIF-4G binds to another translation ini-
tiation factor, eIF-4E, which also binds to the cap. It is this
circular complex, then, that aids in recruiting the 40S ribo-
somal subunit to the mRNA (reviewed in reference 67; see also
reference 102). Is this model applicable to say, mRNAs under-
going poly(A) elongation during oocyte maturation? While it
has not yet been tested in these cells, a number of facets will
almost certainly prove to be correct. For example, a long
poly(A) tail appended to a number of mRNAs is sufficient to
induce their translation following oocyte injection (61, 74, 95).
It would follow, then that these poly(A) tails bind poly(A)
binding protein, which binds eIF-4G, etc., which would result
in translation. On the other hand, it should be borne in mind
that poly(A) binding protein is not abundant in oocytes (110)
and, when it is expressed in moderate amounts by mRNA in-
jection, it disrupts the normal default deadenylation that oc-
curs at maturation (106). Of course, oocytes could contain pro-
teins that perform the same task as poly(A) binding protein but
are structurally distinct and therefore are not detected with
poly(A) binding protein antibody. Indeed, oocyte-specific poly
(A) binding proteins have been observed by UV cross-linking
(87).
Alternatively, oocytes may use a unique translational strat-
egy. In this regard, Kuge and Richter (46) have demonstrated
that during Xenopus oocyte maturation, active poly(A) elon-
gation induces cap-specific 29-O methylation (i.e., cap I and
cap II, which have methyl groups at the 29 position of the first
and second ribose moieties following the triphosphate bridge,
respectively). Two experiments argue that cap ribose methyl-
ation is important for translation: (i) prevention of 29-O meth-
ylation abrogates translational activation with little effect on
FIG. 5. Inhibition of cap ribose methylation abolishes progesterone-induced
Mos synthesis and oocyte maturation in Xenopus. (A and B) Oocytes were
incubated in the indicated concentrations of S-isobutylthioadenosine (SIBA), an
analogue of S-adenosylmethionine, from which methyl groups are donated in
methyltransferase reactions. SIBA is a stable competitive inhibitor of methyl-
transferase reactions. These oocytes were also incubated in the absence (lane 1)
or presence (lanes 2 to 6) of progesterone and analyzed for the polyadenylation
(A) and methylation (B) of injected c-mos mRNA. M refers to a marker for cap
I formation, and N refers to noninjected mRNA processed in an identical
manner. Note that while SIBA had little effect on polyadenylation, cap I and cap
II formation was completely eliminated at 0.5 and 0.75 mM SIBA. (C) Western
blot for Mos protein. Note that while immature oocytes contain no Mos (lane 1),
this protein accumulates during oocyte maturation (lane 2). While SIBA has no
effect on Mos synthesis at the lower concentrations, it completely prevents Mos
accumulation at 0.5 and 0.75 mM. (D) General protein synthesis (i.e., [35S]me-
thionine incorporation) in oocytes was unaffected by SIBA irrespective of con-
centration. (E) Oocyte maturation (as scored by GVBD) paralleled that of Mos
synthesis. That is, the prevention of Mos synthesis by SIBA inhibited oocyte matu-
ration. The bars in panels D and E represent the mean and standard deviation of
three experiments. Reprinted from reference 47 with permission of the publisher.
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polyadenylation (Fig. 5), and (ii) mRNAs that contain cap I
prior to injection are translated more efficiently that those with
cap 0 (i.e., lacking 29-O methylation) (47). However, because
this modification occurs on only a subset of mRNAs that are
polyadenylated at maturation (28), it may be that polyadenyla-
tion induces translation in multiple ways.
CONCLUSIONS AND FUTURE DIRECTIONS
The modulation of poly(A) tail length is clearly an evolu-
tionarily conserved mechanism for regulating mRNA transla-
tion. While much biochemistry remains to be performed be-
fore the details of the process can be understood, a number of
facets deserve particular attention, and these may be placed in
broad categories. The first is that of initial activation. At least
in Xenopus and mouse oocytes, phosphorylation and dephos-
phorylation events seem likely to be the trigger for poly(A)
elongation. However, this conjecture is based on older studies
of oocyte maturation, and we do not know the kinases, or even
the substrates, which are important for polyadenylation. Sec-
ond, does cytoplasmic polyadenylation regulate brain activity
and/or other functions in the adult? In this regard, tissue-
specific CPEB knockout mice, particularly targeted to the hip-
pocampus, would be extraordinarily useful source materials. In
addition, a re-examination of the tissue distribution of CPEB
would certainly be warranted. Third, how does deadenylation
lead to translational silencing in frogs, flies, and worms? Going
further, is there an interaction between the EDEN-BP and
PARN to induce deadenylation in frog oocytes and embryos?
Finally, are there multiple mechanisms of polyadenylation-
induced translation, and, if so, how and why are they appar-
ently mRNA specific? Now that several of the factors involved
in these processes have been cloned, rapid progress in answer-
ing these questions will surely be made.
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